Michael Fabrizio MD, FACS, CEO, Urology of Virginia, Professor of Urology Eastern Virginia Medical School
Advertisement
Articles by Michael Fabrizio MD, FACS, CEO, Urology of Virginia, Professor of Urology Eastern Virginia Medical School
Advertisement
Latest Updated Articles
- Long-term Survival with Immunotherapy in Advanced Prostate Cancer
Published: September 4th 2019 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
Choosing salvage therapy after prostate cancer focal ablation
2
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
3
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
4
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
5
